木瓜直播

Meeting Coverage >

AHA

Ablation Bests Drugs for Ventricular Tachycardia After Heart Attack

VANISH2 trial may set new standard of care for ischemic cardiomyopathy patients

Tirzepatide Officially Puts GLP-1 Meds on the Map for Obesity-Related Heart Failure

SUMMIT trial able to show clinical benefit beyond quality-of-life improvement

Intensive Blood Pressure Control Benefits People With Type 2 Diabetes Too

BPROAD trial replicates SPRINT trial findings in diabetes population in China

Statins Reach More Patients With Pharmacist's Orders

Asynchronous automated order approach boosts statin prescribing

Self-Monitoring Lowers Blood Pressure After Pregnancy Complicated by Hypertension

Intervention trial shows impact that could pay off long-term

Novel PCSK9 Inhibitor Recaticimab Lowers Lipids With Less Frequent Shots

Monoclonal antibody promises substantial lipid lowering with just one injection every 3 months

Lowering the Target for Blood Pressure Is Best, Study Affirms

Huge trial from China reinforces the message from SPRINT for higher-risk hypertensive patients

DOAC Cuts Stroke Risk From Subclinical Afib

But whether the small absolute gain shown in ARTESiA is worth the bleeds is another question

Promising Debut for CRISPR Gene Editing Therapy for LDL Lowering

Preliminary data support concept of "molecular surgery" on PCSK9 gene

Intensive Blood Pressure Lowering Cuts Dementia Risk

Benefit finally proven in clinical trial

Double Defibrillator More Effective for Obese Afib Patients

Clinical trial affirms a better initial strategy

Antihypertensives Do Not Detract From the BP Reduction of a Low-Sodium Diet

Dietary change produces clinically relevant BP changes within a week

No Aspirin Needed After LVAD, ARIES-HM3 Trial Says

Warfarin does a good enough job alone without adding aspirin

Angioplasty Redeemed for Stable Angina in Sham-Controlled ORBITA-2

Reduced angina frequency with anti-anginal meds out of the picture

Transfusion Thresholds Square Off in Acute Myocardial Infarction

For patients with anemia, trial suggests the commonly used restrictive strategy might not be best

And for Wegovy's Next Trick, Full-Blown Cardiovascular Benefit Outside Diabetes

Established weight loss and diabetes drug may extend reach to millions more

Surgery Bests Endovascular Therapy for Most Limb-Threatening Ischemia Patients

Surgical revascularization better for limb events and death when an adequate vein was available

'Groundbreaking' Results With Nasal Spray for Home Tachycardia Conversion

Novel agent shortened episodes versus placebo

Low-Dose 'Quadpill' Reduces High Blood Pressure

Significantly lower diastolic blood pressure at 12 weeks, U.S.-based study showed

Strong Showing for Novel BP-Lowering Drugs in Resistant Hypertension

Aprocitentan targets the endothelin pathway, whereas baxdrostat blocks aldosterone production

Can Botox for the Heart Ward Off Afib After Cardiac Surgery?

Epicardial botulinum toxin generally not better than placebo in the NOVA study

Precision Medicine Strategy Reduced Testing in Patients With Chest Pain

Also reduced risk of composite endpoint of death, MI, and catheterization compared with usual care

Anticoagulation Again Flops for Outpatient COVID-19

Largest-yet RCT shows no benefit for non-hospitalized symptomatic patients despite elevated risk

Upfront ECMO Disappoints for Cardiogenic Shock

High-cost procedure not yet justified as an early strategy

Moving Fast on HF Drugs After Acute Hospitalization Holds Big Outcome Benefit

Randomized trial shows advantages across heart failure spectrum

Bivalirudin Crowned as Better Anticoagulant for Primary PCI in STEMI

BRIGHT-4 trial hands the drug a "clear, unambiguous win" against heparin

Early Invasive Strategy for Stable CAD Holds No Long-Term Survival Advantage

Extended follow-up of ISCHEMIA trial weighs in on mortality

Experts Agree Intravenous Iron Shows Promise for Heart Failure Patients

While findings were not significant, the study was impacted by COVID lockdowns, researcher says

Study Refutes Heart Health Claims of Dietary Supplements

LDL cholesterol reductions with cinnamon, garlic, and others not on par with statin

Decision-Support Tool Enhances Outcomes for Heart Failure Patients in the ED

Pathways for HF patients picked for early discharge versus admission

Definitive Answer on Steroids for Infant Heart Surgery Falls Short

STRESS trial misses primary endpoint but secondary benefits are suggestive

Diuretics on Par in Head-to-Head Comparison for Hypertension

But a surprise signal emerges for one group in pragmatic trial

Mixed Results With Pemafibrate in Patients With Type 2 Diabetes

No impact on CV events in PROMINENT; developer brings trial to an end

Furosemide Holds Up to Newer, Stronger Loop Diuretic During HF Hospitalization

Preference for mainstay decongestant versus torsemide likely unchanged after TRANSFORM-HF study

Bentracimab on Point as Fast-Acting Ticagrelor Reversal Agent

"Immediate and sustained" benefit, interim REVERSE-IT analysis found

Oral Factor XIa Inhibitor Sets the Stage for a Safer Anticoagulant

Milvexian shows promise in preventing vein clots after total knee replacement surgery

Oral PCSK9 Inhibitor Slashed Cholesterol

Reductions of 65% observed in phase I trials

Potent Antiplatelet Not a Good Idea for Moderate COVID-19

ACTIV-4a trial suggests harm for hospitalized patients outside the ICU

Hospitalized Acute HF Patients See Clinical Benefits With Empagliflozin

EMPULSE results support early start for the SGLT2 inhibitor, but more data needed, expert says

Vascepa Succumbs as COVID Treatment in 'Underpowered' Trial

Purified fish oil didn't help SARS-CoV-2-positive outpatients

1